[ACRX] YoY Quarter Result on 30-Sep-2014 [#Q3]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
10-Nov-2014
Financial Year
2014
Quarter
30-Sep-2014 [#Q3]
Profit Trend
QoQ- 106.35%
YoY- 106.11%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Revenue 1,487 3,366 15,428 4,825 548 166 408 24.02%
PBT -13,013 -11,438 5,841 671 -10,986 -8,582 -5,761 14.53%
Tax -3,233 -36 772 6,556 -1,980 390 356 -
NP -13,013 -11,402 5,069 671 -10,986 -8,582 -5,761 14.53%
Tax Rate - - -13.22% -977.05% - - - -
Total Cost 14,500 14,768 10,359 4,154 11,534 8,748 6,169 15.29%
Ratio Analysis
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
NP Margin -875.12 -338.74 32.86 13.91 -2,004.74 -5,169.88 -1,412.01 -7.65%
Per Share
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
EPS -5.61 -5.03 2.20 0.40 -5.30 -7.58 -5.92 -0.89%
EPS Diluted -5.61 -5.03 2.20 -2.60 -5.30 -7.58 -5.92 -0.89%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.